Showing results 5 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Is there a role for hormone replacement therapy after breast cancer? Journal:British Menopause Society Journal | 2005 | 55 | ||
JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency Journal:Nature Communications | 2020 | 39 | ||
NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming Journal:Nature Cell Biology | 2018 | 61 | ||
2021 | 18 | |||
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Journal:New England Journal of Medicine | Piccart-Gebhart, MJProcter, MLeyland-Jones, BGoldhirsch, AUntch, MSmith, IGianni, LBaselga, JBell, RJackisch, CCameron, DDowsett, MBarrios, CHSteger, GHuang, CSAndersson, MInbar, MLichinitser, MLáng, INitz, UIwata, HThomssen, CLohrisch, CSuter, TMRüschoff, JSütő, TGreatorex, VWard, CStraehle, CMcFadden, EDolci, SGelber, RDHerceptin Adjuvant (HERA) Trial Study TeamKwong, A | 2005 |